Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 664
Selected: 0
NCT IDTitle
NCT00132886Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
NCT01440920A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients
NCT01488266Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
NCT05463770A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia
NCT02968121Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia
NCT00549978Safety and Pharmacokinetics of Probucol and Cilostazol
NCT01634243A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients
NCT01723904A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
NCT00361790Aripiprazole and Lexapro Drug Interaction Study
NCT03902574Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg
NCT05615363A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
NCT00095511Aripiprazole in Patients With Acute Mania
NCT03393520Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT00818324Long Term Administration Study of OPC-12759 Ophthalmic Suspension
NCT05248646Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)
NCT01795105ABF Tourette's Disorder Post Marketing Surveillance Study
NCT00279409Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
NCT01727700Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT02545101An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH
NCT01876381A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
NCT03303092Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine
NCT02168920Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT04331132Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction
NCT02446132Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT03568500A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT07058233Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial
NCT01432444Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT02554721Pharmacodynamic Study of Cilostazol in Healthy Volunteers
NCT01199198Tolvaptan in Hyponatremic Cancer Patients
NCT00401271Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis
NCT04786574A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
NCT02364947A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
NCT01057147Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
NCT00102193Study for the Treatment of Ulcerative Colitis With Adacolumn
NCT01429831Aripiprazole for the Augmentation of Antidepressant Therapy
NCT01552772Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
NCT01779401Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
NCT01444885Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina
NCT03734172Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)
NCT01632137Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
NCT04030143A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
NCT01043250Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
NCT01562743A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
NCT05683340A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
NCT00874497Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
NCT03896945Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia
NCT01987960Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
NCT02006641Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
NCT00545142Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
NCT03420222Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder